Biotinylated Human Coagulation Factor III / Tissue Factor Protein, His,Avitag™ (MALS & SPR verified)

Customer Reviews
Cat. No. / Size
Price
Qty
TF3-H82E3-25ug
$360.00
TF3-H82E3-200ug
$1565.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    Coagulation Factor III, Tissue Factor, TF, F3, CD142

  • Source

    Biotinylated Human Tissue Factor Protein, His,Avitag (TF3-H82E3) is expressed from human 293 cells (HEK293). It contains AA Ser 33 - Glu 251 (Accession # P13726-1).

    Predicted N-terminus: Ser 33

    Request for sequence
  • Molecular Characterization

    Coagulation Factor III Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 28.4 kDa. The protein migrates as 38-43 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    Coagulation Factor III SDS-PAGE

    Biotinylated Human Tissue Factor Protein, His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Coagulation Factor III SEC-MALS

    The purity of Biotinylated Human Tissue Factor Protein, His,Avitag (Cat. No. TF3-H82E3) is more than 90% and the molecular weight of this protein is around 30-45 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     Coagulation Factor III ELISA

    Immobilized Tisotumab at 1 μg/mL (100 μL/well) can bind Biotinylated Human Tissue Factor Protein, His,Avitag (Cat. No. TF3-H82E3) with a linear range of 0.06-1 ng/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     Coagulation Factor III SPR

    Biotinylated Human Tissue Factor Protein, His,Avitag (Cat. No. TF3-H82E3) captured on Biotin CAP-Series S Sensor Chip can bind Tisotumab with an affinity constant of 26.9 pM as determined in a SPR assay (Biacore 8K) (QC tested).

    Protocol
  • Bioactivity

    Measured by its ability to activate Coagulation Factor VII in cleaving a fluorogenic peptide substrate BOC-Val-Pro-Arg-AMC. The AC50 is <4.0 μg/mL (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Full-length tissue factor (TF) is a transmembrane receptor and cofactor for factor (F)VII/FVIIa. In addition to full-length TF, an alternative spliced (as) form of TF can be generated that lacks the transmembrane domain and is released fromcells. In contrast to TF, asTF has low procoagulant activity because it lacks the transmembrane domain. Tissue factor is expressed by cells around blood vessels, such as adventitial fibroblasts, and body surfaces, such as epithelial cells, and plays a critical role in hemostasis. TF also contributes to various forms of thrombosis. Many cancers, particularly adenocarcinomas, express high levels of TF. A high level of tumor TF expression is associated with poor prognosis in many types of cancers, including breast, prostate, colorectal, and pancreatic cancer.

Recent Advances

 
Drug Development Progress
  • English Name:

    Tissue factor

  • Category:

  • Approved Drugs:

    1 Details

  • Drugs in Clinical Trials:

    8 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8